• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

近期心肌梗死后低步行障碍问卷评分可识别患有多血管疾病的患者。

Low Walking Impairment Questionnaire score after a recent myocardial infarction identifies patients with polyvascular disease.

作者信息

Jönelid Birgitta, Kragsterman Björn, Berglund Lars, Andrén Bertil, Johnston Nina, Lindahl Bertil, Oldgren Jonas, Christersson Christina

机构信息

Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.

Department of Surgical Sciences, Vascular Surgery, Uppsala University, Uppsala, Sweden.

出版信息

JRSM Cardiovasc Dis. 2019 Apr 16;8:2048004019841971. doi: 10.1177/2048004019841971. eCollection 2019 Jan-Dec.

DOI:10.1177/2048004019841971
PMID:31019682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6469275/
Abstract

OBJECTIVES

To evaluate whether the Walking Impairment Questionnaire score could identify patients with polyvascular disease in a population with recent myocardial infarction and their association with cardiovascular events during two-year follow-up.

DESIGN

A prospective observational study.

SETTING

Patients admitted to the acute coronary care unit, the Department of Cardiology, Uppsala University Hospital.

PARTICIPANTS

Patients admitted with acute Non-STEMI- or STEMI-elevation myocardial infarction.

MAIN OUTCOME MEASURES

The Walking Impairment Questionnaire, developed as a self-administered instrument to assess , , and in patients with peripheral artery disease, predicts future cardiovascular events and mortality. Two hundred and sixty-three patients with recent myocardial infarction answered Walking Impairment Questionnaire. Polyvascular disease was defined as abnormal findings in the coronary- and carotid arteries and an abnormal ankle-brachial index. The calculated score for each of all three categories were divided into quartiles with the lowest score in first quartile.

RESULTS

The lowest (worst) quartile in all three Walking Impairment Questionnaire categories was associated with polyvascular disease, fully adjusted; , odds ratio (OR) 5.4 (95% confidence interval (CI) 1.8-16.1); , OR 7.4 (95% CI 1.5-36.5); , OR 8.4 (95% CI 1.0-73.6). In , patients with the lowest (worst) score had a higher risk for the composite cardiovascular endpoint compared to the highest (best) score; hazard ratio 5.3 (95% CI 1.5-19.0). The adherence to medical treatment was high (between 81.7% and 99.2%).

CONCLUSIONS

The Walking Impairment Questionnaire is a simple tool to identify myocardial infarction patients with more widespread atherosclerotic disease and although well treated medically, stair climbing predicts cardiovascular events.

摘要

目的

评估步行障碍问卷评分能否在近期心肌梗死患者群体中识别出患有多血管疾病的患者,以及在两年随访期间其与心血管事件的关联。

设计

一项前瞻性观察性研究。

地点

乌普萨拉大学医院心脏病科急性冠脉护理病房收治的患者。

参与者

因急性非ST段抬高型或ST段抬高型心肌梗死入院的患者。

主要观察指标

步行障碍问卷是一种作为自我管理工具开发的,用于评估外周动脉疾病患者的[具体评估内容缺失],可预测未来心血管事件和死亡率。263例近期心肌梗死患者回答了步行障碍问卷。多血管疾病定义为冠状动脉和颈动脉存在异常发现以及踝臂指数异常。所有三个类别各自的计算得分被分为四分位数,第一四分位数得分最低。

结果

在所有三个步行障碍问卷类别中,最低(最差)四分位数与多血管疾病相关,经过充分调整;[具体内容缺失],比值比(OR)5.4(95%置信区间(CI)1.8 - 16.1);[具体内容缺失],OR 7.4(95% CI 1.5 - 36.5);[具体内容缺失],OR 8.4(95% CI 1.0 - 73.6)。在[具体内容缺失]方面,得分最低(最差)的患者与得分最高(最佳)的患者相比,发生复合心血管终点事件的风险更高;风险比5.3(95% CI 1.5 - 19.0)。药物治疗依从性较高(在81.7%至99.2%之间)。

结论

步行障碍问卷是一种简单的工具,可用于识别患有更广泛动脉粥样硬化疾病的心肌梗死患者,并且尽管接受了良好的药物治疗,但爬楼梯能力可预测心血管事件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e5/6469275/0a8459f497ee/10.1177_2048004019841971-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e5/6469275/9dd65951c8f6/10.1177_2048004019841971-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e5/6469275/72664c1c391b/10.1177_2048004019841971-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e5/6469275/0a8459f497ee/10.1177_2048004019841971-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e5/6469275/9dd65951c8f6/10.1177_2048004019841971-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e5/6469275/72664c1c391b/10.1177_2048004019841971-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e5/6469275/0a8459f497ee/10.1177_2048004019841971-fig3.jpg

相似文献

1
Low Walking Impairment Questionnaire score after a recent myocardial infarction identifies patients with polyvascular disease.近期心肌梗死后低步行障碍问卷评分可识别患有多血管疾病的患者。
JRSM Cardiovasc Dis. 2019 Apr 16;8:2048004019841971. doi: 10.1177/2048004019841971. eCollection 2019 Jan-Dec.
2
The Walking Impairment Questionnaire stair-climbing score predicts mortality in men and women with peripheral arterial disease.行走障碍问卷爬楼梯评分可预测外周动脉疾病患者的死亡率(无论性别)。
J Vasc Surg. 2012 Jun;55(6):1662-73.e2. doi: 10.1016/j.jvs.2011.12.010.
3
Declining walking impairment questionnaire scores are associated with subsequent increased mortality in peripheral artery disease.步行能力障碍问卷评分下降与外周动脉疾病患者随后的死亡率增加相关。
J Am Coll Cardiol. 2013 Apr 30;61(17):1820-9. doi: 10.1016/j.jacc.2013.01.060. Epub 2013 Feb 28.
4
Ankle brachial index most important to identify polyvascular disease in patients with non-ST elevation or ST-elevation myocardial infarction.踝臂指数对于识别非 ST 段抬高或 ST 段抬高型心肌梗死患者的多血管疾病最为重要。
Eur J Intern Med. 2016 May;30:55-60. doi: 10.1016/j.ejim.2015.12.016. Epub 2016 Jan 8.
5
Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Journal of the American Medical Association 2013; 309: 453-460.雷米普利对伴有间歇性跛行的外周动脉疾病患者行走时间和生活质量的影响:一项随机对照试验。美国医学会杂志 2013;309:453-460.
Vasc Med. 2013 Aug;18(4):234-6. doi: 10.1177/1358863X13497529. Epub 2013 Jul 18.
6
Nine-Month Outcomes of the DURABILITY Iliac Study on Self-Expanding Stents for Symptomatic Peripheral Artery Disease.关于有症状外周动脉疾病的自膨胀支架的DURABILITY髂动脉研究的九个月结果
Ann Vasc Surg. 2018 Aug;51:37-47. doi: 10.1016/j.avsg.2018.02.020. Epub 2018 Apr 18.
7
Walking impairment questionnaire improves mortality risk prediction models in a high-risk cohort independent of peripheral arterial disease status.步行障碍问卷可改善高危队列中死亡风险预测模型,且独立于外周动脉疾病状态。
Circ Cardiovasc Qual Outcomes. 2013 May 1;6(3):255-61. doi: 10.1161/CIRCOUTCOMES.111.000070. Epub 2013 Apr 30.
8
Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial.多血管疾病、2 型糖尿病与长期血管风险:来自 IMPROVE-IT 试验的二次分析。
Lancet Diabetes Endocrinol. 2018 Dec;6(12):934-943. doi: 10.1016/S2213-8587(18)30290-0. Epub 2018 Nov 2.
9
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial.依洛尤单抗治疗多血管疾病及近期急性冠状动脉综合征患者:ODYSSEY OUTCOMES 试验。
J Am Coll Cardiol. 2019 Sep 3;74(9):1167-1176. doi: 10.1016/j.jacc.2019.03.013. Epub 2019 Mar 18.
10
Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.多血管疾病与外周动脉疾病主要不良心血管事件风险:EUCLID 试验的二次分析。
JAMA Netw Open. 2018 Nov 2;1(7):e185239. doi: 10.1001/jamanetworkopen.2018.5239.

引用本文的文献

1
Physical Activity After Treatment for Symptomatic Peripheral Artery Disease.症状性外周动脉疾病治疗后的体力活动。
Am J Cardiol. 2021 Jan 1;138:107-113. doi: 10.1016/j.amjcard.2020.10.011. Epub 2020 Oct 13.

本文引用的文献

1
The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients.指南治疗的心肌梗死患者凝血活性预测死亡率和心血管事件风险的效用。
Ups J Med Sci. 2017 Nov;122(4):224-233. doi: 10.1080/03009734.2017.1407849. Epub 2018 Jan 4.
2
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).2017年欧洲心脏病学会(ESC)与欧洲血管外科学会(ESVS)合作制定的外周动脉疾病诊断和治疗指南:涵盖颅外颈动脉和椎动脉、肠系膜、肾、上肢和下肢动脉粥样硬化疾病的文件 认可机构:欧洲卒中组织(ESO) 欧洲心脏病学会(ESC)和欧洲血管外科学会(ESVS)外周动脉疾病诊断和治疗特别工作组
Eur Heart J. 2018 Mar 1;39(9):763-816. doi: 10.1093/eurheartj/ehx095.
3
Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).编辑推荐——2017年欧洲心脏病学会(ESC)与欧洲血管外科学会(ESVS)合作制定的外周动脉疾病诊断和治疗指南
Eur J Vasc Endovasc Surg. 2018 Mar;55(3):305-368. doi: 10.1016/j.ejvs.2017.07.018. Epub 2017 Aug 26.
4
Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.外周动脉疾病作为动脉粥样硬化疾病初始或后续表现患者的心血管结局:一项瑞典全国性研究的结果
J Vasc Surg. 2017 Aug;66(2):507-514.e1. doi: 10.1016/j.jvs.2017.01.067. Epub 2017 Apr 19.
5
The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected: A Meta-Analysis of Mortality and Disease Progression in Peripheral Arterial Disease.外周动脉疾病的疾病进展风险高于预期:一项外周动脉疾病死亡率和疾病进展的荟萃分析。
Eur J Vasc Endovasc Surg. 2016 Mar;51(3):395-403. doi: 10.1016/j.ejvs.2015.10.022. Epub 2016 Jan 6.
6
Ankle brachial index most important to identify polyvascular disease in patients with non-ST elevation or ST-elevation myocardial infarction.踝臂指数对于识别非 ST 段抬高或 ST 段抬高型心肌梗死患者的多血管疾病最为重要。
Eur J Intern Med. 2016 May;30:55-60. doi: 10.1016/j.ejim.2015.12.016. Epub 2016 Jan 8.
7
Comprehensive analysis of cardiopulmonary exercise testing and mortality in patients with systolic heart failure: the Henry Ford Hospital cardiopulmonary exercise testing (FIT-CPX) project.综合分析收缩性心力衰竭患者的心肺运动试验和死亡率:亨利福特医院心肺运动试验(FIT-CPX)项目。
J Card Fail. 2015 Sep;21(9):710-8. doi: 10.1016/j.cardfail.2015.06.001. Epub 2015 Jun 9.
8
Impact of peripheral artery disease on prognosis in hospitalized heart failure patients.外周动脉疾病对住院心力衰竭患者预后的影响。
Circ J. 2015;79(4):785-93. doi: 10.1253/circj.CJ-14-1280. Epub 2015 Jan 28.
9
Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective.心肌梗死后患者的心血管风险:全国真实世界数据表明长期视角的重要性。
Eur Heart J. 2015 May 14;36(19):1163-70. doi: 10.1093/eurheartj/ehu505. Epub 2015 Jan 13.
10
Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010.1990年至2010年全球及21个世界区域外周动脉疾病所致死亡和残疾负担
Glob Heart. 2014 Mar;9(1):145-158.e21. doi: 10.1016/j.gheart.2013.12.008.